US20110022159A1 - Porous membranes for medical implants and methods of manufacture - Google Patents
Porous membranes for medical implants and methods of manufacture Download PDFInfo
- Publication number
- US20110022159A1 US20110022159A1 US12/895,032 US89503210A US2011022159A1 US 20110022159 A1 US20110022159 A1 US 20110022159A1 US 89503210 A US89503210 A US 89503210A US 2011022159 A1 US2011022159 A1 US 2011022159A1
- Authority
- US
- United States
- Prior art keywords
- porous membrane
- layer porous
- membrane
- traces
- pores
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H3/00—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length
- D04H3/02—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of forming fleeces or layers, e.g. reorientation of yarns or filaments
- D04H3/07—Non-woven fabrics formed wholly or mainly of yarns or like filamentary material of substantial length characterised by the method of forming fleeces or layers, e.g. reorientation of yarns or filaments otherwise than in a plane, e.g. in a tubular way
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/15—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor incorporating preformed parts or layers, e.g. extrusion moulding around inserts
- B29C48/151—Coating hollow articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/25—Component parts, details or accessories; Auxiliary operations
- B29C48/92—Measuring, controlling or regulating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/01—Filters implantable into blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91508—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91558—Adjacent bands being connected to each other connected peak to peak
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2948/00—Indexing scheme relating to extrusion moulding
- B29C2948/92—Measuring, controlling or regulating
- B29C2948/92504—Controlled parameter
- B29C2948/92571—Position, e.g. linear or angular
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2948/00—Indexing scheme relating to extrusion moulding
- B29C2948/92—Measuring, controlling or regulating
- B29C2948/92504—Controlled parameter
- B29C2948/9258—Velocity
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2948/00—Indexing scheme relating to extrusion moulding
- B29C2948/92—Measuring, controlling or regulating
- B29C2948/92504—Controlled parameter
- B29C2948/9258—Velocity
- B29C2948/9259—Angular velocity
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2948/00—Indexing scheme relating to extrusion moulding
- B29C2948/92—Measuring, controlling or regulating
- B29C2948/92504—Controlled parameter
- B29C2948/9258—Velocity
- B29C2948/926—Flow or feed rate
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2948/00—Indexing scheme relating to extrusion moulding
- B29C2948/92—Measuring, controlling or regulating
- B29C2948/92504—Controlled parameter
- B29C2948/92609—Dimensions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2948/00—Indexing scheme relating to extrusion moulding
- B29C2948/92—Measuring, controlling or regulating
- B29C2948/92504—Controlled parameter
- B29C2948/92609—Dimensions
- B29C2948/92628—Width or height
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2948/00—Indexing scheme relating to extrusion moulding
- B29C2948/92—Measuring, controlling or regulating
- B29C2948/92504—Controlled parameter
- B29C2948/92695—Viscosity; Melt flow index [MFI]; Molecular weight
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C2948/00—Indexing scheme relating to extrusion moulding
- B29C2948/92—Measuring, controlling or regulating
- B29C2948/92819—Location or phase of control
- B29C2948/92857—Extrusion unit
- B29C2948/92904—Die; Nozzle zone
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/001—Combinations of extrusion moulding with other shaping operations
- B29C48/0012—Combinations of extrusion moulding with other shaping operations combined with shaping by internal pressure generated in the material, e.g. foaming
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
- B29C48/03—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the shape of the extruded material at extrusion
- B29C48/07—Flat, e.g. panels
- B29C48/08—Flat, e.g. panels flexible, e.g. films
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2023/00—Use of polyalkenes or derivatives thereof as moulding material
- B29K2023/04—Polymers of ethylene
- B29K2023/06—PE, i.e. polyethylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2023/00—Use of polyalkenes or derivatives thereof as moulding material
- B29K2023/10—Polymers of propylene
- B29K2023/12—PP, i.e. polypropylene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2027/00—Use of polyvinylhalogenides or derivatives thereof as moulding material
- B29K2027/12—Use of polyvinylhalogenides or derivatives thereof as moulding material containing fluorine
- B29K2027/18—PTFE, i.e. polytetrafluorethene, e.g. ePTFE, i.e. expanded polytetrafluorethene
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2067/00—Use of polyesters or derivatives thereof, as moulding material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2071/00—Use of polyethers, e.g. PEEK, i.e. polyether-etherketone or PEK, i.e. polyetherketone or derivatives thereof, as moulding material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2075/00—Use of PU, i.e. polyureas or polyurethanes or derivatives thereof, as moulding material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2077/00—Use of PA, i.e. polyamides, e.g. polyesteramides or derivatives thereof, as moulding material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/04—Condition, form or state of moulded material or of the material to be shaped cellular or porous
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
- B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
- B29K2105/06—Condition, form or state of moulded material or of the material to be shaped containing reinforcements, fillers or inserts
- B29K2105/08—Condition, form or state of moulded material or of the material to be shaped containing reinforcements, fillers or inserts of continuous length, e.g. cords, rovings, mats, fabrics, strands or yarns
- B29K2105/10—Cords, strands or rovings, e.g. oriented cords, strands or rovings
- B29K2105/101—Oriented
- B29K2105/108—Oriented arranged in parallel planes and crossing at substantial angles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7532—Artificial members, protheses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/755—Membranes, diaphragms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
- Y10T428/24273—Structurally defined web or sheet [e.g., overall dimension, etc.] including aperture
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
- Y10T428/24273—Structurally defined web or sheet [e.g., overall dimension, etc.] including aperture
- Y10T428/24298—Noncircular aperture [e.g., slit, diamond, rectangular, etc.]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/24—Structurally defined web or sheet [e.g., overall dimension, etc.]
- Y10T428/24273—Structurally defined web or sheet [e.g., overall dimension, etc.] including aperture
- Y10T428/24298—Noncircular aperture [e.g., slit, diamond, rectangular, etc.]
- Y10T428/24306—Diamond or hexagonal
Definitions
- the present invention relates to porous membranes suitable for covering medical implants such as stents for intravascular delivery, implants covered with such membranes and methods for making the porous membranes.
- Covered stents for implantation into a body vessel, duct or lumen generally include a stent and a cover attached to the stent.
- a porous structure of the cover depending on the porosity, may enhance tissue ingrowth after the covered stent has been implanted.
- a porous structure affixed to an implantable device also may serve as a reservoir for bioactive components and/or reduce embolization by trapping thrombus against a vessel wall.
- Porous membranes for use in medical devices are known in the art.
- U.S. Pat. No. 4,759,757 to Pinchuk describes the formation of a porous membrane by leaching water soluble inorganic salts incorporated into the membrane to create pores where the salt crystals were initially located.
- U.S. Pat. No. 6,540,776 to Sanders Millare et al. describes a perforated membrane in which a pattern of interstices is created by removing material, for example, by laser cutting. The foregoing manufacturing methods require at least two process steps to form a porous membrane.
- U.S. Pat. No. 4,738,740 to Pinchuk et al. describes a spinning method similar to that of Wong and further comprising intermittently applying a electrostatic charge to ensure reattachment of broken fibers to the mandrel.
- U.S. Pat. No. 5,653,747 to Dereume describes a vascular graft with an expandable coating produced by the spinning technique of Wong and having pores that open when the tubular support member expands.
- a membrane comprising a plurality of fibers that are deposited onto a substrate with a predetermined and reproducible pattern.
- the substrate may be either a mandrel or a surface of an implantable device, such as a stent.
- the fibers comprise a polymer that is sufficiently elastic and robust that the membrane follows the movements of the stent from loading onto a stent delivery system to deployment and implantation, without adversely affecting the performance of the membrane of the stent.
- the membrane is formed using a computer-controller substrate that moves in a precisely controlled and reproducible manner.
- the polymer used to form the fibers e.g., a polyurethane or a copolymer thereof, is dissolved in a solvent and extruded through one or more extrusion heads onto a moving substrate.
- the number of passes, substrate shape and motion and extrusion head speed and material flow are controlled to provide a predetermined fiber diameter that is deposited to produce desired membrane properties, such as pore size and density.
- the membrane may either be fixed on the exterior surface of an implantable device, such as a stent, on the interior surface or both. Where an exterior covering is desired, the membrane may be directly deposited on the implantable device. Alternatively, the covering may be deposited on a mandrel to form a separate component, and then affixed to the implantable device in a later manufacturing step.
- the membrane may comprise composite fibers having a viscous sheath co-extruded around a solid core component, or alternatively may comprise co-extruded viscous components.
- a membrane may be created wherein the individual fibers are loaded with a desired bioactive agent, such as a drug, that elutes from the matrix of the membrane without resulting in substantial degradation of the mechanical properties of the membrane.
- FIG. 1 is a schematic depiction of a membrane manufacturing system constructed in accordance with the principles of the present invention
- FIGS. 2A-2C are perspective views depicting exemplary patterns for depositing fibers onto a moving substrate in accordance with the present invention
- FIG. 3 is a perspective view illustrating a stent covered with the membrane of the present invention.
- FIG. 4 is a schematic depiction of a membrane manufacturing process wherein the fibers comprise a core filament having a polymeric sheath;
- FIG. 5 is a schematic depiction of a membrane manufacturing process wherein the fibers comprise a coextrusion of two polymers.
- the present invention generally relates to medical implants, such as stents, having a porous membrane and the methods of making such membranes and medical implants.
- polymer membranes are provided that have well-defined pores based on a controlled deposition of fibers onto a substrate. In this manner a permeable membrane having a predetermined pore size and distribution may be obtained.
- Covered stents for treatment of atherosclerotic lesions constructed according to the present invention comprise a porous membrane bonded to an exterior surface, and interior surface, or both, of a stent.
- the covered stent of the present invention may serve both to reduce embolization during an interventional procedure and prevent late embolization by tethering emboli and particles to the vessel wall.
- the inventive membrane may be engineered to provide any of a number of design properties, including: single and multi-component material composition; loading of one or more physiological (bioactive) substances into the polymer matrix; predetermined isotropic or an-isotropic mechanical properties; and predetermined pore geometry.
- polymeric material is deposited onto a computer-controlled movable substrate. Controlling the relative location and motion of the material source with regard to the deposition location on the substrate and process parameters, such as material flow and viscosity of the deposited material, permits generation of a multitude of different patterns for the membrane.
- the porous membrane of the present invention is sufficiently strong and flexible for use in medical devices, and preferably comprises steps of extruding a continuous fiber-forming biocompatible polymeric material through a reciprocating extrusion head onto a substrate to form an elongated fiber.
- the fiber is deposited on the substrate in a predetermined pattern in traces having a width of from 5 to 500 micrometers, adjacent traces being spaced apart from each other a distance of between o and 500 micrometers.
- the fibers have a predetermined viscous creep that allows adjacent traces to bond to one another at predetermined contact points upon deposition.
- the number of overlapping or crossing fibers generally should be less than 5, preferably less than 4, and most preferably 1 or 2.
- the biocompatible material provides a stable, porous membrane.
- apparatus 10 suitable for forming the porous membranes of the present invention comprises polymer extrusion machine 11 coupled to numerically controlled positioning system 12 .
- Computer 13 controls the flow of extrudate 14 through extrusion head 15 as well as relative motion of extrusion head 15 and substrate 16 resulting from actuation of positioning system 12 .
- Apparatus 10 permits highly-localized deposition of the extrudate with four degrees of freedom onto a substrate to form a membrane.
- the degrees of freedom are: z—the longitudinal motion of substrate 16 relative to extrusion head 15 ; ⁇ —the angular movement of substrate 16 relative to extrusion head 15 ; r—the distance between extrusion head 15 and substrate 16 ; and ⁇ —the pivotal angle of extrusion head 15 .
- the polymer strands 17 may be deposited onto the substrate under computer control to form any of the patterns described herein below.
- the substrate comprises a rotating mandrel.
- Polymer is extruded through reciprocating extrusion head 15 representing the first degree of freedom z, and with a controlled distance between the extrusion head and substrate 16 , representing the second degree of freedom r.
- the distance between the extrusion head and substrate is between 0 to 50 mm, and more preferably between 0.5 and 20 mm.
- the substrate is rotated through a predetermined angle ⁇ , corresponding to the third degree of freedom.
- fibers 17 extruded from extrusion head 15 form a two-dimensional membrane on substrate 16 .
- fourth degree of freedom ⁇ may be employed, thus making it possible to deposit more than one filament simultaneously while maintaining a set inter-fiber distance.
- the four degrees of freedom discussed above may be independently controlled and if needed, synchronized, to attain a spatial resolution of material deposition having an order of magnitude of microns or higher.
- the second degree of freedom r may be fixed if stable polymer deposition has been achieved.
- the fourth degree of freedom is not required when extruding only one filament.
- Extrusion head 15 may have one or more outlets to deposit an extruded polymer fiber onto substrate 16 in traces having an inter-trace distance ranging between 0 to 1000 micrometers.
- the width of the individual trace (corresponding to the fiber width) may vary between 5 to 500 micrometers, and more preferably is in the range of 10 to 200 micrometers.
- Pore size is a function of trace width and inter-trace distance and may be selected by selection of these variables from between 0 (i.e., a tight covering) to 200 micrometers (i.e., to form a filter or tether to trap emboli against a vessel wall) Due to the precise control of fiber deposition, it is possible to create a membrane with desired porosity, strength and flexibility with a very small number of overlapping traces or crossing traces.
- the number of overlapping or crossing traces in the membrane of the present invention generally should be less than 5, preferably less than 4, and most preferably 1 to 2.
- the biocompatible polymer is liquefied either by dissolving the biocompatible material in solvents or by thermally melting the biocompatible material, or both.
- the viscosity of the liquefied material determines the viscous creep properties and thus final pore size and inter-pore distance when the material is deposited on the substrate.
- the viscous creep is controlled so that desired geometrical and physical properties are met upon deposition.
- the specified inter-pore distance, pore width and inter-fiber bonding may be achieved.
- the substrate may be heated to facilitate relaxation and/or curing of the trace width after deposition on the substrate.
- Viscosity also may be controlled by adjustment of the distance r of extrusion head 15 relative to substrate 16 , the concentration of the solvent in extrudate 14 and/or the heating temperature, ambient pressure, and extrusion parameters. With the viscous creep of the fibers being appropriately controlled, the traces deposited on the substrate will bond to one another at predetermined contact points upon deposition.
- a specified pore size of the membrane may be achieved by, but is not limited to, lateral deposition distance between two adjacent material traces, extrusion parameters, and/or extrusion head outlet diameters and extrusion pressure. The latter two parameters also affect the fiber diameter, thus in combination with the fiber deposition pattern selected, permit selection and control of the mechanical properties of the membrane.
- Suitable biocompatible materials include but are not limited to polyurethane and copolymers thereof, silicone polyurethane copolymer, polypropylene and copolymers thereof, polyamides, polyethylenes, PET, PEEK, ETFE, CTFE, PTFE and copolymers thereof.
- Preferred materials for forming membranes of the present invention are polyurethane and copolymers thereof.
- the polymers may in addition include any biologically active substance having desired release kinetics upon implantation into a patient's body.
- membrane 20 is formed on substrate 16 having diameter D by reciprocating extrusion head 15 longitudinally relative to the longitudinal axis of the substrate, followed by indexed angular movement of the substrate while the extrusion head is held stationary at the ends of the substrate. In this manner, traces 21 having a controlled width and inter-trace spacing may be deposited on the substrate.
- the substrate is rotated 3600 while the extrusion head is indexed along the length of the substrate, thereby forming a regular pattern of square or rectangular pores having a predetermined size.
- extrusion head 15 is provided with multiple outlets, multiple parallel fibers may be deposited in a single longitudinal pass.
- FIG. 2B illustrates alternative membrane pattern 22 , wherein the substrate is rotated through precise angular motions during longitudinal translation of the extrusion head.
- the pattern of FIG. 2B includes a series of “jogs” 23 in each longitudinal filament 24 .
- the contacting portions of the traces bond to one another to define pores 25 having a predetermined size. In this manner, with each longitudinal pass of the extrusion head, a line of pores 25 of predetermined size in formed in a single layer membrane.
- FIG. 2C shows another pattern 26 by which the membrane of the present invention may be built up.
- positioning system 12 employs two degrees of freedom, z and ⁇ , simultaneously, resulting in a “braid-like” structure.
- the extruded fibers retain a high unevaporated solvent content when deposited on substrate 16 , so that the fibers fuse to form a unitary structure having a predetermined pore size.
- apparatus 10 may be used to deposit one or more traces of a biocompatible material on substrate 16 while extrusion head 15 is reciprocated along the length of the substrate.
- An extrusion head having multiple outlets permit the deposition of multiple filaments on the substrate during a single translation of the extrusion head or rotation of the substrate. All translational and rotational motions of the components of apparatus 10 are individually or synchronously controlled by computer 13 , thus permitting the membrane to be configured with any desired pattern.
- apparatus 10 permits fibers to be deposited with any of a number of possible alternative patterns.
- two trace layers may be generated that cross or overlap to form a membrane having a regular grid of pores. In this case, only one degree of freedom is used at any one time.
- a series of “jogs” may be introduced into the individual fibers. In this case, the traces do not cross but only contact each other, thereby creating a line of pores in a single layer membrane.
- a braided structure such as depicted in FIG. 2C may be obtained, in which a specified pore size and shape is attained by varying the distance between two parallel traces of material.
- extrusion is performed with chemically or thermally liquefied material, or both.
- the viscosity of the extrudate may be controlled by the concentration of the solvent, by enhancing evaporation of the solvent from the deposited material trace by means of heating the substrate, by varying the distance r between the extrusion head and the substrate, or by adjusting the extrusion temperature of the material so that a well-defined viscous creep of the material occurs after deposition onto the substrate.
- Adjustment of the viscous creep allows fusion of the traces at contact points and thus formation of a two-dimensional membrane having desired mechanical strength characteristics.
- accurate material deposition may be achieved with reduced lateral aberrations of the filaments compared to previously-known membrane manufacturing techniques.
- the diameter of the substrate should be selected based upon the dimensions of the medical implant or stent to which the membrane is to be affixed.
- the diameter may be selected based upon the expanded configuration of the medical implant or stent.
- the implant to be covered may be balloon-expandable or self-expandable.
- the implant is a self-expandable stent comprising a superelastic material such as a nickel-titanium alloy.
- Stent 30 covered with membrane 31 of the present invention is described.
- Stent 30 may comprise any suitable design, such as a plastically deformable slotted tube or self-expanding superelastic structure.
- Porous membrane 31 may be deposited directly onto the medical implant, such as stent 30 which is employed as the substrate during the membrane deposition process.
- the membrane may be deposited on a mandrel and after curing may be bonded in a separate step to the medical implant.
- thermal drying and/or evaporation of the solvent cures the biocompatible material while on the substrate.
- the membrane may be bonded to a surface of the implant using a solvent, adhesive or thermal technique.
- the surface of the implant may be pre-processed to optimize bonding, for example by activation of the surface, coating of the surface with liquified polymer or other appropriate treatments of the surface.
- membrane 40 comprises multi-component fiber 41 including core filament 42 coated with at least second biocompatible material 43 having the same or different chemical, physical, mechanical, biocompatible and or biologically active properties.
- Material 43 may incorporate one or more biologically active substances that elute into the patient's bloodstream after the medical implant is implanted.
- Multi-component fiber 41 may be deposited onto the substrate to form a two-dimensional contiguous structure.
- the individual components of fiber 41 may be selected to provide different characteristics to the membrane, which may employ any of the pattern designs discussed herein above.
- core filament 42 may provide mechanical stability, while material 43 may serve as and interface to the biological environment, enhance the adhesive properties for inter-trace bonding and/or enhance bonding of the membrane to the medical implant.
- Suitable materials for the core filament include but are not limited to polyamides, polyethylenes, PET, PEEK, ETFE, CTFE, and PTFE and copolymers thereof, and metal wire or fiber glass.
- Suitable materials for ensheathing core filament 41 include but are not limited to polyurethane and copolymers thereof, silicone polyurethane copolymer, polypropylene and copolymers thereof, polyamides, polyethylenes, PET, PEEK, ETFE, CTFE, PTFE and copolymers thereof.
- membrane 50 comprises co-extruded fibers 51 formed of at least first biocompatible material 52 and second biocompatible material 53 .
- Materials 52 and 53 may have the same or different chemical, physical, mechanical, biocompatible and or physiologically active properties.
- Fibers 51 while illustrated as being co-axially co-extruded, alternatively may be co-extruded co-linearly.
- Suitable materials for first material 52 include but are not limited to polyamides, polyethylenes, PET, PEEK, ETFE, CTFE, PTFE and copolymers thereof.
- Suitable materials for second material 53 include but are not limited to polyurethane and copolymers thereof, silicone polyurethane copolymer, polypropylene and copolymers thereof, polyamides, polyethylenes, PET, PEEK, ETFE, CTFE, PTFE and copolymers thereof.
- the present invention is not limited to membranes for use on stents. Rather, the membranes of the present invention may be affixed to any other medical device or implant that is brought into an intracorporal lumen for limited or extended implant durations. Such devices include vascular protection devices to filter emboli that are only transiently introduced into the body. Further applications for such porous membranes may be devices configured to be introduced into other body lumens or ducts, such as the trachea, esophagus, and biliary or urinary lumina.
Abstract
The present invention involves porous polymer membranes, suitable for use in medical implants, having controlled pore sizes, pore densities and mechanical properties. Methods of manufacturing such porous membranes are described in which a continuous fiber of polymer is extruded through a reciprocating extrusion head and deposited onto a substrate in a predetermined pattern. When cured, the polymeric material forms a stable, porous membrane suitable for a variety of applications, including reducing emboli release during and after stent delivery, and providing a source for release of bioactive substances to a vessel or organ and surrounding tissue.
Description
- The present application is a continuation of U.S. patent application Ser. No. 11/313,110, filed Dec. 19, 2005, which claims the benefit of and priority to U.S. provisional patent application Ser. No. 60/637,495, filed Dec. 20, 2004, and is also a continuation-in-part of U.S. patent application Ser. No. 10/859,636, filed Jun. 3, 2004, which is a continuation of U.S. patent application Ser. No. 09/967,789, filed Sep. 28, 2001.
- 1. The Field of the Invention
- The present invention relates to porous membranes suitable for covering medical implants such as stents for intravascular delivery, implants covered with such membranes and methods for making the porous membranes.
- 2. The Relevant Technology
- Covered stents for implantation into a body vessel, duct or lumen generally include a stent and a cover attached to the stent. A porous structure of the cover, depending on the porosity, may enhance tissue ingrowth after the covered stent has been implanted. A porous structure affixed to an implantable device also may serve as a reservoir for bioactive components and/or reduce embolization by trapping thrombus against a vessel wall.
- Porous membranes for use in medical devices are known in the art. For example, U.S. Pat. No. 4,759,757 to Pinchuk describes the formation of a porous membrane by leaching water soluble inorganic salts incorporated into the membrane to create pores where the salt crystals were initially located. U.S. Pat. No. 6,540,776 to Sanders Millare et al. describes a perforated membrane in which a pattern of interstices is created by removing material, for example, by laser cutting. The foregoing manufacturing methods require at least two process steps to form a porous membrane.
- One step processes for forming porous membranes also are known in the art, for example, using spinning techniques. U.S. Patent Application Publication No. 20040051201 to Greenhalgh et al. describes an electrospinning process in which a membrane is formed from a plurality of randomly-oriented, intertangled, nonwoven fibrils.
- Spinning techniques that produce less random, but non-uniform membranes, also are known. For example, U.S. Pat. No. 4,475,972 to Wong describes a porous polymeric material made by a process in which polymeric fibers are wound on a mandrel in multiple overlying layers. The fibers contain unevaporated solvent when deposited in contact with one another, so that upon evaporation of the solvent the fibers bond together. The fibers laid in one traverse are wound on the mandrel parallel to each other and at an angle with respect to the axis of the mandrel. In the next traverse, the angle of winding is reverse to the previous angle, so that the fibers crisscross each other in multiple layers to form the porous structure.
- U.S. Pat. No. 4,738,740 to Pinchuk et al. describes a spinning method similar to that of Wong and further comprising intermittently applying a electrostatic charge to ensure reattachment of broken fibers to the mandrel. U.S. Pat. No. 5,653,747 to Dereume describes a vascular graft with an expandable coating produced by the spinning technique of Wong and having pores that open when the tubular support member expands.
- All of the foregoing spinning processes suffer from an inability to tightly control the pore size and pore pattern of the resulting membranes. More specifically, lateral deviation of the fibers using previously known spinning techniques has resulted in unsteady collocation of the fibers and the need to deposit multiple layers to ensure adequate coverage. Consequently, previously-known techniques produce either stiff membranes formed of multiple layers and unsatisfactory porosity, or porous, elastic membranes with insufficient strength.
- In view of the foregoing, it would be desirable to provide membranes having controlled porosity, pore pattern and pore distribution.
- It further would be desirable to provide a one step manufacturing process to produce membranes having controlled porosity, pore pattern and pore distribution.
- It still further would be desirable to provide a one step manufacturing process to produce membranes having controlled porosity and/or pore pattern wherein the membrane includes a bioactive substance that may be eluted from the membrane after implantation.
- It also would be desirable to provide manufacturing processes to produce membranes having the desired porosity, pattern and distribution characteristics for use in medical implants.
- In view of the foregoing, it is an object of the present invention to provide membranes for use in medical implants having controlled porosity, pore pattern and pore distribution.
- It is another object of this invention to provide a one step manufacturing process to produce membranes having controlled porosity, pore pattern and pore distribution.
- It is a further object of the present invention to provide a one step manufacturing process to produce membranes having controlled porosity and/or pore pattern wherein the membrane includes a bioactive substance that may be eluted from the membrane after implantation.
- It is also an object of this invention to provide manufacturing processes to produce membranes having the desired porosity, pattern and distribution characteristics for use in medical implants.
- These and other objects of the present invention are accomplished by providing a membrane comprising a plurality of fibers that are deposited onto a substrate with a predetermined and reproducible pattern. The substrate may be either a mandrel or a surface of an implantable device, such as a stent. In a preferred embodiment, the fibers comprise a polymer that is sufficiently elastic and robust that the membrane follows the movements of the stent from loading onto a stent delivery system to deployment and implantation, without adversely affecting the performance of the membrane of the stent.
- In a preferred embodiment, the membrane is formed using a computer-controller substrate that moves in a precisely controlled and reproducible manner. The polymer used to form the fibers, e.g., a polyurethane or a copolymer thereof, is dissolved in a solvent and extruded through one or more extrusion heads onto a moving substrate. By moving the extrusion head back and forth with a specific velocity along the axis of the substrate, specific filament angles or patterns may be deposited. In accordance with one aspect of the present invention, the number of passes, substrate shape and motion and extrusion head speed and material flow are controlled to provide a predetermined fiber diameter that is deposited to produce desired membrane properties, such as pore size and density.
- The membrane may either be fixed on the exterior surface of an implantable device, such as a stent, on the interior surface or both. Where an exterior covering is desired, the membrane may be directly deposited on the implantable device. Alternatively, the covering may be deposited on a mandrel to form a separate component, and then affixed to the implantable device in a later manufacturing step.
- In accordance with another aspect of the present invention, the membrane may comprise composite fibers having a viscous sheath co-extruded around a solid core component, or alternatively may comprise co-extruded viscous components. In this manner, a membrane may be created wherein the individual fibers are loaded with a desired bioactive agent, such as a drug, that elutes from the matrix of the membrane without resulting in substantial degradation of the mechanical properties of the membrane.
- Methods of manufacturing covered implantable medical devices including the porous membranes of the present invention also are provided.
- Further features of the invention, its nature and various advantages will be more apparent from the accompanying drawings and the following detailed description of the preferred embodiments, in which:
-
FIG. 1 is a schematic depiction of a membrane manufacturing system constructed in accordance with the principles of the present invention; -
FIGS. 2A-2C are perspective views depicting exemplary patterns for depositing fibers onto a moving substrate in accordance with the present invention; -
FIG. 3 is a perspective view illustrating a stent covered with the membrane of the present invention; -
FIG. 4 is a schematic depiction of a membrane manufacturing process wherein the fibers comprise a core filament having a polymeric sheath; and -
FIG. 5 is a schematic depiction of a membrane manufacturing process wherein the fibers comprise a coextrusion of two polymers. - The present invention generally relates to medical implants, such as stents, having a porous membrane and the methods of making such membranes and medical implants. In accordance with the present invention, polymer membranes are provided that have well-defined pores based on a controlled deposition of fibers onto a substrate. In this manner a permeable membrane having a predetermined pore size and distribution may be obtained.
- Acute as well as late embolization are a significant threat during and after intravascular interventions such as stenting in saphenous vein grafts (SVG) and carotid arteries, where released particles can lead to major cardiac attacks or strokes, respectively. Covered stents for treatment of atherosclerotic lesions constructed according to the present invention comprise a porous membrane bonded to an exterior surface, and interior surface, or both, of a stent. Advantageously, the covered stent of the present invention may serve both to reduce embolization during an interventional procedure and prevent late embolization by tethering emboli and particles to the vessel wall.
- The inventive membrane may be engineered to provide any of a number of design properties, including: single and multi-component material composition; loading of one or more physiological (bioactive) substances into the polymer matrix; predetermined isotropic or an-isotropic mechanical properties; and predetermined pore geometry.
- In accordance with the principles of the present invention, polymeric material is deposited onto a computer-controlled movable substrate. Controlling the relative location and motion of the material source with regard to the deposition location on the substrate and process parameters, such as material flow and viscosity of the deposited material, permits generation of a multitude of different patterns for the membrane.
- The porous membrane of the present invention is sufficiently strong and flexible for use in medical devices, and preferably comprises steps of extruding a continuous fiber-forming biocompatible polymeric material through a reciprocating extrusion head onto a substrate to form an elongated fiber. The fiber is deposited on the substrate in a predetermined pattern in traces having a width of from 5 to 500 micrometers, adjacent traces being spaced apart from each other a distance of between o and 500 micrometers.
- Preferably, the fibers have a predetermined viscous creep that allows adjacent traces to bond to one another at predetermined contact points upon deposition. The number of overlapping or crossing fibers generally should be less than 5, preferably less than 4, and most preferably 1 or 2. When cured, the biocompatible material provides a stable, porous membrane.
- Referring to
FIG. 1 ,apparatus 10 suitable for forming the porous membranes of the present invention comprises polymer extrusion machine 11 coupled to numerically controlledpositioning system 12.Computer 13 controls the flow ofextrudate 14 throughextrusion head 15 as well as relative motion ofextrusion head 15 andsubstrate 16 resulting from actuation ofpositioning system 12. -
Apparatus 10 permits highly-localized deposition of the extrudate with four degrees of freedom onto a substrate to form a membrane. The degrees of freedom are: z—the longitudinal motion ofsubstrate 16 relative toextrusion head 15; φ—the angular movement ofsubstrate 16 relative toextrusion head 15; r—the distance betweenextrusion head 15 andsubstrate 16; and θ—the pivotal angle ofextrusion head 15. Thepolymer strands 17 may be deposited onto the substrate under computer control to form any of the patterns described herein below. - In a preferred embodiment, the substrate comprises a rotating mandrel. Polymer is extruded through reciprocating
extrusion head 15 representing the first degree of freedom z, and with a controlled distance between the extrusion head andsubstrate 16, representing the second degree of freedom r. Preferably, the distance between the extrusion head and substrate is between 0 to 50 mm, and more preferably between 0.5 and 20 mm. As the polymer is deposited onto the substrate, the substrate is rotated through a predetermined angle φ, corresponding to the third degree of freedom. In this manner,fibers 17 extruded fromextrusion head 15 form a two-dimensional membrane onsubstrate 16. In addition, by pivoting the extrusion head along its vertical axis, fourth degree of freedom θ may be employed, thus making it possible to deposit more than one filament simultaneously while maintaining a set inter-fiber distance. - The four degrees of freedom discussed above may be independently controlled and if needed, synchronized, to attain a spatial resolution of material deposition having an order of magnitude of microns or higher. Optionally, the second degree of freedom r may be fixed if stable polymer deposition has been achieved. The fourth degree of freedom is not required when extruding only one filament.
-
Extrusion head 15 may have one or more outlets to deposit an extruded polymer fiber ontosubstrate 16 in traces having an inter-trace distance ranging between 0 to 1000 micrometers. The width of the individual trace (corresponding to the fiber width) may vary between 5 to 500 micrometers, and more preferably is in the range of 10 to 200 micrometers. Pore size is a function of trace width and inter-trace distance and may be selected by selection of these variables from between 0 (i.e., a tight covering) to 200 micrometers (i.e., to form a filter or tether to trap emboli against a vessel wall) Due to the precise control of fiber deposition, it is possible to create a membrane with desired porosity, strength and flexibility with a very small number of overlapping traces or crossing traces. The number of overlapping or crossing traces in the membrane of the present invention generally should be less than 5, preferably less than 4, and most preferably 1 to 2. - The biocompatible polymer is liquefied either by dissolving the biocompatible material in solvents or by thermally melting the biocompatible material, or both. The viscosity of the liquefied material determines the viscous creep properties and thus final pore size and inter-pore distance when the material is deposited on the substrate. Preferably, the viscous creep is controlled so that desired geometrical and physical properties are met upon deposition. By controlling the viscosity and amount of the deposited material on the substrate and consequently the viscous creep of the polymer before curing, the specified inter-pore distance, pore width and inter-fiber bonding may be achieved. Alternatively, the substrate may be heated to facilitate relaxation and/or curing of the trace width after deposition on the substrate.
- Viscosity also may be controlled by adjustment of the distance r of
extrusion head 15 relative tosubstrate 16, the concentration of the solvent inextrudate 14 and/or the heating temperature, ambient pressure, and extrusion parameters. With the viscous creep of the fibers being appropriately controlled, the traces deposited on the substrate will bond to one another at predetermined contact points upon deposition. - A specified pore size of the membrane may be achieved by, but is not limited to, lateral deposition distance between two adjacent material traces, extrusion parameters, and/or extrusion head outlet diameters and extrusion pressure. The latter two parameters also affect the fiber diameter, thus in combination with the fiber deposition pattern selected, permit selection and control of the mechanical properties of the membrane.
- Suitable biocompatible materials include but are not limited to polyurethane and copolymers thereof, silicone polyurethane copolymer, polypropylene and copolymers thereof, polyamides, polyethylenes, PET, PEEK, ETFE, CTFE, PTFE and copolymers thereof. Preferred materials for forming membranes of the present invention are polyurethane and copolymers thereof. The polymers may in addition include any biologically active substance having desired release kinetics upon implantation into a patient's body.
- Referring now to
FIGS. 2A to 2C , exemplary patterns formed byapparatus 10 during deposition of the fibers fromextrusion head 15 of the present invention are described. InFIG. 2A ,membrane 20 is formed onsubstrate 16 having diameter D by reciprocatingextrusion head 15 longitudinally relative to the longitudinal axis of the substrate, followed by indexed angular movement of the substrate while the extrusion head is held stationary at the ends of the substrate. In this manner, traces 21 having a controlled width and inter-trace spacing may be deposited on the substrate. - Once the longitudinal fibers have been deposited on the substrate, the substrate is rotated 3600 while the extrusion head is indexed along the length of the substrate, thereby forming a regular pattern of square or rectangular pores having a predetermined size. Alternatively, if
extrusion head 15 is provided with multiple outlets, multiple parallel fibers may be deposited in a single longitudinal pass. -
FIG. 2B illustratesalternative membrane pattern 22, wherein the substrate is rotated through precise angular motions during longitudinal translation of the extrusion head. Instead of depositing a straight longitudinal strand, as in the pattern ofFIG. 2A , the pattern ofFIG. 2B includes a series of “jogs” 23 in eachlongitudinal filament 24. Whenadjacent filaments 24 are deposited on the substrate, the contacting portions of the traces bond to one another to definepores 25 having a predetermined size. In this manner, with each longitudinal pass of the extrusion head, a line ofpores 25 of predetermined size in formed in a single layer membrane. -
FIG. 2C shows anotherpattern 26 by which the membrane of the present invention may be built up. In this embodiment,positioning system 12 employs two degrees of freedom, z and φ, simultaneously, resulting in a “braid-like” structure. Preferably the extruded fibers retain a high unevaporated solvent content when deposited onsubstrate 16, so that the fibers fuse to form a unitary structure having a predetermined pore size. - More generally,
apparatus 10 may be used to deposit one or more traces of a biocompatible material onsubstrate 16 whileextrusion head 15 is reciprocated along the length of the substrate. An extrusion head having multiple outlets permit the deposition of multiple filaments on the substrate during a single translation of the extrusion head or rotation of the substrate. All translational and rotational motions of the components ofapparatus 10 are individually or synchronously controlled bycomputer 13, thus permitting the membrane to be configured with any desired pattern. - As discussed above with respect to
FIGS. 2A-2C ,apparatus 10 permits fibers to be deposited with any of a number of possible alternative patterns. By depositing the fibers first in multiple passes longitudinal passes followed by indexed translation of the extrusion head and simultaneous rotation of the substrate, as inFIG. 2A , two trace layers may be generated that cross or overlap to form a membrane having a regular grid of pores. In this case, only one degree of freedom is used at any one time. Alternatively, addressing two degrees of freedom alternatingly, as in the pattern ofFIG. 2B , a series of “jogs” may be introduced into the individual fibers. In this case, the traces do not cross but only contact each other, thereby creating a line of pores in a single layer membrane. Still further, by addressing two degrees of freedom simultaneously, a braided structure such as depicted inFIG. 2C may be obtained, in which a specified pore size and shape is attained by varying the distance between two parallel traces of material. - In accordance with one aspect of the present invention, extrusion is performed with chemically or thermally liquefied material, or both. The viscosity of the extrudate may be controlled by the concentration of the solvent, by enhancing evaporation of the solvent from the deposited material trace by means of heating the substrate, by varying the distance r between the extrusion head and the substrate, or by adjusting the extrusion temperature of the material so that a well-defined viscous creep of the material occurs after deposition onto the substrate.
- Adjustment of the viscous creep allows fusion of the traces at contact points and thus formation of a two-dimensional membrane having desired mechanical strength characteristics. By appropriately setting these parameters accurate material deposition may be achieved with reduced lateral aberrations of the filaments compared to previously-known membrane manufacturing techniques.
- As will of course be understood, the diameter of the substrate should be selected based upon the dimensions of the medical implant or stent to which the membrane is to be affixed. For example, the diameter may be selected based upon the expanded configuration of the medical implant or stent. The implant to be covered may be balloon-expandable or self-expandable. In a preferred embodiment, the implant is a self-expandable stent comprising a superelastic material such as a nickel-titanium alloy.
- Referring to
FIG. 3 ,stent 30 covered withmembrane 31 of the present invention is described.Stent 30 may comprise any suitable design, such as a plastically deformable slotted tube or self-expanding superelastic structure.Porous membrane 31 may be deposited directly onto the medical implant, such asstent 30 which is employed as the substrate during the membrane deposition process. - Alternatively, the membrane may be deposited on a mandrel and after curing may be bonded in a separate step to the medical implant. In the latter case, thermal drying and/or evaporation of the solvent cures the biocompatible material while on the substrate. Once the membrane has cured sufficiently so that the mechanical properties of the membrane permit it to be removed from the substrate, the membrane may be bonded to a surface of the implant using a solvent, adhesive or thermal technique. In this case, the surface of the implant may be pre-processed to optimize bonding, for example by activation of the surface, coating of the surface with liquified polymer or other appropriate treatments of the surface.
- Referring now to
FIG. 4 , an alternative method of forming a porous membrane, suitable for use in a medical implant, is described. In this embodiment,membrane 40 comprisesmulti-component fiber 41 includingcore filament 42 coated with at least secondbiocompatible material 43 having the same or different chemical, physical, mechanical, biocompatible and or biologically active properties.Material 43 may incorporate one or more biologically active substances that elute into the patient's bloodstream after the medical implant is implanted. -
Multi-component fiber 41 may be deposited onto the substrate to form a two-dimensional contiguous structure. The individual components offiber 41 may be selected to provide different characteristics to the membrane, which may employ any of the pattern designs discussed herein above. For example,core filament 42 may provide mechanical stability, whilematerial 43 may serve as and interface to the biological environment, enhance the adhesive properties for inter-trace bonding and/or enhance bonding of the membrane to the medical implant. - Suitable materials for the core filament include but are not limited to polyamides, polyethylenes, PET, PEEK, ETFE, CTFE, and PTFE and copolymers thereof, and metal wire or fiber glass. Suitable materials for ensheathing
core filament 41 include but are not limited to polyurethane and copolymers thereof, silicone polyurethane copolymer, polypropylene and copolymers thereof, polyamides, polyethylenes, PET, PEEK, ETFE, CTFE, PTFE and copolymers thereof. - Referring to
FIG. 5 , a further alternative method of forming the porous membrane of the present invention is described. In the method depicted inFIG. 5 ,membrane 50 comprisesco-extruded fibers 51 formed of at least firstbiocompatible material 52 and secondbiocompatible material 53.Materials Fibers 51, while illustrated as being co-axially co-extruded, alternatively may be co-extruded co-linearly. - Suitable materials for
first material 52 include but are not limited to polyamides, polyethylenes, PET, PEEK, ETFE, CTFE, PTFE and copolymers thereof. Suitable materials forsecond material 53 include but are not limited to polyurethane and copolymers thereof, silicone polyurethane copolymer, polypropylene and copolymers thereof, polyamides, polyethylenes, PET, PEEK, ETFE, CTFE, PTFE and copolymers thereof. - It should be understood that the present invention is not limited to membranes for use on stents. Rather, the membranes of the present invention may be affixed to any other medical device or implant that is brought into an intracorporal lumen for limited or extended implant durations. Such devices include vascular protection devices to filter emboli that are only transiently introduced into the body. Further applications for such porous membranes may be devices configured to be introduced into other body lumens or ducts, such as the trachea, esophagus, and biliary or urinary lumina.
- While preferred illustrative embodiments of the invention are described above, it will be apparent to one skilled in the art that various changes and modifications may be made therein without departing from the invention. The appended claims are intended to cover all such changes and modifications that fall within the true spirit and scope of the invention.
Claims (26)
1. A single-layer porous membrane for use in medical implants comprising:
an elongated fiber having a width of 5 to 500 micrometers, the elongated fiber forming a plurality of non-crossing traces extending adjacently from a first end to a second end of the membrane, each trace contacting its adjacent traces in an alternating manner, adjacent traces being bonded together at points of contact, the traces defining a plurality of pores of predetermined sizes.
2. The single-layer porous membrane of claim 1 , wherein the plurality of pores have essentially the same size.
3. The single-layer porous membrane of claim 1 , wherein the membrane has a thickness substantially equal to the thickness of the elongated fiber.
4. The single-layer porous membrane of claim 1 , wherein the elongated fiber comprises a bio-compatible material.
5. The single-layer porous membrane of claim 1 , wherein the elongated fiber is continuous.
6. The single-layer porous membrane of claim 1 , wherein at least one of the plurality of pores has an essentially square shape.
7. The single-layer porous membrane of claim 1 , wherein at least one of the plurality of pores has an essentially diamond shape.
8. The single-layer porous membrane of claim 1 , wherein at least one of the plurality of pores has an essentially rectangular shape.
9. The single-layer porous membrane of claim 1 , wherein adjacent traces have an inter-trace distance of between 0 and 200 micrometers.
10. The single-layer porous membrane of claim 1 , wherein the elongated fiber comprises a multi-component fiber.
11. The single-layer porous membrane of claim 10 , wherein the multi-component fiber comprises a core filament comprising a first material, the core filament being disposed within a second material.
12. The single-layer porous membrane of claim 11 , wherein the second material includes one or more biologically active substances.
13. The single-layer porous membrane of claim 12 , wherein the second material is configured to deliver the one or more biologically active substances.
14. The single-layer porous membrane of claim 13 , wherein the one or more biologically active substances are configured to be eluted from the second material.
15. The single-layer porous membrane of claim 11 , wherein the first material is selected from the group consisting of polyamide, polyethylene, PET, PEEK, ETFE, CTFE, PTFE, metal, and fiberglass.
16. The single-layer porous membrane of claim 11 , wherein the second material is selected from the group consisting of polyurethane and copolymers thereof, silicone polyurethane, polypropylene and copolymers thereof, polyamide, polyethylene, PET, PEEK, ETFE, CTFE, and PTFE.
17. A single-layer porous membrane for use with medical implants comprising:
a continuous elongated fiber having a width of 5 to 500 micrometers forming a predetermined pattern of non-crossing traces, the traces extending adjacently from a first end to a second end of the membrane, each trace being bonded at contact portions to its adjacent traces, the contact portions being spaced apart, the traces defining a plurality of pores of predetermined sizes, the membrane having a thickness approximately equal to the thickness of the fiber.
18. The single-layer porous membrane of claim 17 , wherein the plurality of pores have a dimension between 1 and 500 micrometers.
19. The single-layer porous membrane of claim 17 , wherein the elongated fiber comprises a polymeric sheath surrounding a solid core filament.
20. The single-layer porous membrane of claim 19 , wherein the solid core filament is co-axially positioned within the polymeric sheath.
21. An implantable medical device comprising:
a medical implant;
a single-layer porous membrane coupled to the medical implant, the single-layer porous membrane comprising:
an elongated fiber of bio-compatible material having a width of 5 to 500 micrometers, the elongated fiber forming a plurality of non-crossing traces extending adjacently from a first end to a second end of the membrane, each trace contacting its adjacent traces in an alternating manner, adjacent traces being bonded together at points of contact, the traces defining a plurality of pores of predetermined sizes.
22. The implantable medical device of claim 21 , wherein the medical implant is a vascular implant.
23. The implantable medical device of claim 22 , wherein the vascular implant is a stent.
24. The implantable medical device of claim 22 , wherein the vascular implant is a filter.
25. The implantable medical device of claim 22 , wherein the membrane is thermally bonded to the medical implant.
26. The implantable medical device of claim 22 , wherein the membrane is bonded to the medical implant with an adhesive.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/895,032 US20110022159A1 (en) | 2001-09-28 | 2010-09-30 | Porous membranes for medical implants and methods of manufacture |
US13/801,469 US20130190856A1 (en) | 1998-09-05 | 2013-03-13 | Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/967,789 US6755856B2 (en) | 1998-09-05 | 2001-09-28 | Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
US10/859,636 US7927364B2 (en) | 1998-09-05 | 2004-06-03 | Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
US63749504P | 2004-12-20 | 2004-12-20 | |
US11/313,110 US7815763B2 (en) | 2001-09-28 | 2005-12-19 | Porous membranes for medical implants and methods of manufacture |
US12/895,032 US20110022159A1 (en) | 2001-09-28 | 2010-09-30 | Porous membranes for medical implants and methods of manufacture |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/313,110 Continuation US7815763B2 (en) | 1998-09-05 | 2005-12-19 | Porous membranes for medical implants and methods of manufacture |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/801,469 Continuation-In-Part US20130190856A1 (en) | 1998-09-05 | 2013-03-13 | Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20110022159A1 true US20110022159A1 (en) | 2011-01-27 |
Family
ID=46323411
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/313,110 Expired - Fee Related US7815763B2 (en) | 1998-09-05 | 2005-12-19 | Porous membranes for medical implants and methods of manufacture |
US12/895,032 Abandoned US20110022159A1 (en) | 1998-09-05 | 2010-09-30 | Porous membranes for medical implants and methods of manufacture |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/313,110 Expired - Fee Related US7815763B2 (en) | 1998-09-05 | 2005-12-19 | Porous membranes for medical implants and methods of manufacture |
Country Status (1)
Country | Link |
---|---|
US (2) | US7815763B2 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080294239A1 (en) * | 2007-05-23 | 2008-11-27 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with elevated scaffolding properties |
US20100328087A1 (en) * | 2009-06-28 | 2010-12-30 | Oki Data Corporation | Communication apparatus, connection control method for communication apparatus and method of determining state of communication plug relative to communication connector in communication apparatus |
US20110004289A1 (en) * | 1998-09-05 | 2011-01-06 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for a stent having an expandable web structure |
US20110135806A1 (en) * | 2009-12-03 | 2011-06-09 | David Grewe | Manufacturing methods for covering endoluminal prostheses |
US8246674B2 (en) | 2007-12-20 | 2012-08-21 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having struts linked by foot extensions |
US8343208B2 (en) | 1998-09-05 | 2013-01-01 | Abbott Laboratories Vascular Enterprises Limited | Stent having an expandable web structure |
US8795577B2 (en) | 2007-11-30 | 2014-08-05 | Cook Medical Technologies Llc | Needle-to-needle electrospinning |
US8814926B2 (en) | 1998-09-05 | 2014-08-26 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
US9175427B2 (en) | 2011-11-14 | 2015-11-03 | Cook Medical Technologies Llc | Electrospun patterned stent graft covering |
US9320627B2 (en) | 2007-05-23 | 2016-04-26 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
US20160331512A1 (en) * | 2009-08-07 | 2016-11-17 | Zeus Industrial Products, Inc. | Prosthetic device including electrostatically spun fibrous layer & method for making the same |
US9856588B2 (en) | 2009-01-16 | 2018-01-02 | Zeus Industrial Products, Inc. | Electrospinning of PTFE |
US20180139364A1 (en) * | 2013-02-15 | 2018-05-17 | Red.Com, Llc | Dense field imaging |
US10010395B2 (en) | 2012-04-05 | 2018-07-03 | Zeus Industrial Products, Inc. | Composite prosthetic devices |
US10154918B2 (en) | 2012-12-28 | 2018-12-18 | Cook Medical Technologies Llc | Endoluminal prosthesis with fiber matrix |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2843097C (en) | 2005-05-24 | 2015-10-27 | Inspire M.D Ltd. | Stent apparatuses for treatment via body lumens and methods of use |
US8043323B2 (en) * | 2006-10-18 | 2011-10-25 | Inspiremd Ltd. | In vivo filter assembly |
US8961586B2 (en) | 2005-05-24 | 2015-02-24 | Inspiremd Ltd. | Bifurcated stent assemblies |
CN102836023B (en) | 2006-10-18 | 2015-12-02 | 印斯拜尔Md有限公司 | The support casing of braiding |
CN101578078B (en) | 2006-11-22 | 2013-01-02 | 印斯拜尔Md有限公司 | Optimized stent jacket |
US20090043380A1 (en) * | 2007-08-09 | 2009-02-12 | Specialized Vascular Technologies, Inc. | Coatings for promoting endothelization of medical devices |
US20090043330A1 (en) * | 2007-08-09 | 2009-02-12 | Specialized Vascular Technologies, Inc. | Embolic protection devices and methods |
US20090112239A1 (en) * | 2007-10-31 | 2009-04-30 | Specialized Vascular Technologies, Inc. | Sticky dilatation balloon and methods of using |
US8337544B2 (en) | 2007-12-20 | 2012-12-25 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having flexible connectors |
US8920488B2 (en) | 2007-12-20 | 2014-12-30 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having a stable architecture |
US9068282B2 (en) * | 2008-04-08 | 2015-06-30 | Trustees Of Tufts College | System and method for making biomaterial structures |
US20100119578A1 (en) * | 2008-11-07 | 2010-05-13 | Specialized Vascular Technologies, Inc. | Extracellular matrix modulating coatings for medical devices |
US11305501B2 (en) * | 2009-06-25 | 2022-04-19 | Beijing Advanced Medical Technologies, Co., Ltd. | Methods and apparatus for fabricating porous three-dimensional tubular scaffolds |
US10166128B2 (en) | 2011-01-14 | 2019-01-01 | W. L. Gore & Associates. Inc. | Lattice |
US9839540B2 (en) | 2011-01-14 | 2017-12-12 | W. L. Gore & Associates, Inc. | Stent |
US9744033B2 (en) | 2011-04-01 | 2017-08-29 | W.L. Gore & Associates, Inc. | Elastomeric leaflet for prosthetic heart valves |
US9554806B2 (en) | 2011-09-16 | 2017-01-31 | W. L. Gore & Associates, Inc. | Occlusive devices |
US9510935B2 (en) | 2012-01-16 | 2016-12-06 | W. L. Gore & Associates, Inc. | Articles including expanded polytetrafluoroethylene membranes with serpentine fibrils and having a discontinuous fluoropolymer layer thereon |
US9931193B2 (en) | 2012-11-13 | 2018-04-03 | W. L. Gore & Associates, Inc. | Elastic stent graft |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US10279084B2 (en) | 2012-12-19 | 2019-05-07 | W. L. Gore & Associates, Inc. | Medical balloon devices and methods |
US9968443B2 (en) | 2012-12-19 | 2018-05-15 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
CN103431925B (en) * | 2013-05-03 | 2015-08-12 | 清华大学 | A kind of multiple degrees of freedom pneumatic many shower nozzles complicated tissue organ manufacturing system |
US11911258B2 (en) | 2013-06-26 | 2024-02-27 | W. L. Gore & Associates, Inc. | Space filling devices |
US10842918B2 (en) | 2013-12-05 | 2020-11-24 | W.L. Gore & Associates, Inc. | Length extensible implantable device and methods for making such devices |
CN104287875A (en) * | 2014-03-05 | 2015-01-21 | 青岛尤尼科技有限公司 | Multifunctional bioprinting system and tissue engineering organ preparation method based on bioprinting system |
US9827094B2 (en) | 2014-09-15 | 2017-11-28 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
CN104207859B (en) * | 2014-09-16 | 2016-09-28 | 清华大学 | Rotation method of piling is utilized to prepare method and the special equipment of histoorgan |
EP3088090B1 (en) * | 2015-04-30 | 2019-09-04 | HINTERKOPF GmbH | Varnishing device and method of coating an external surface of a varnishing object |
JP2018515246A (en) | 2015-05-14 | 2018-06-14 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | Devices and methods for atrial appendage occlusion |
EP3386734B1 (en) * | 2015-12-11 | 2021-11-10 | Massachusetts Institute Of Technology | Methods for deposition-based three-dimensional printing |
EP3445282B1 (en) | 2016-04-21 | 2023-06-28 | W. L. Gore & Associates, Inc. | Diametrically adjustable endoprostheses |
CA3072814C (en) | 2017-09-27 | 2023-01-03 | W.L. Gore & Associates, Inc. | Prosthetic valve with expandable frame and associated systems and methods |
US11173023B2 (en) | 2017-10-16 | 2021-11-16 | W. L. Gore & Associates, Inc. | Medical devices and anchors therefor |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
Citations (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4738740A (en) * | 1985-11-21 | 1988-04-19 | Corvita Corporation | Method of forming implantable vascular grafts |
US4743252A (en) * | 1986-01-13 | 1988-05-10 | Corvita Corporation | Composite grafts |
US4759757A (en) * | 1984-04-18 | 1988-07-26 | Corvita Corporation | Cardiovascular graft and method of forming same |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US5015253A (en) * | 1989-06-15 | 1991-05-14 | Cordis Corporation | Non-woven endoprosthesis |
US5019090A (en) * | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5116360A (en) * | 1990-12-27 | 1992-05-26 | Corvita Corporation | Mesh composite graft |
EP0565251A1 (en) * | 1992-03-25 | 1993-10-13 | Cook Incorporated | Vascular stent |
US5282823A (en) * | 1992-03-19 | 1994-02-01 | Medtronic, Inc. | Intravascular radially expandable stent |
US5292331A (en) * | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
US5378239A (en) * | 1990-04-12 | 1995-01-03 | Schneider (Usa) Inc. | Radially expandable fixation member constructed of recovery metal |
US5380299A (en) * | 1993-08-30 | 1995-01-10 | Med Institute, Inc. | Thrombolytic treated intravascular medical device |
US5449382A (en) * | 1992-11-04 | 1995-09-12 | Dayton; Michael P. | Minimally invasive bioactivated endoprosthesis for vessel repair |
US5514154A (en) * | 1991-10-28 | 1996-05-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents |
US5527354A (en) * | 1991-06-28 | 1996-06-18 | Cook Incorporated | Stent formed of half-round wire |
US5591224A (en) * | 1992-03-19 | 1997-01-07 | Medtronic, Inc. | Bioelastomeric stent |
US5591197A (en) * | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
US5593442A (en) * | 1995-06-05 | 1997-01-14 | Localmed, Inc. | Radially expansible and articulated vessel scaffold |
US5593417A (en) * | 1995-11-27 | 1997-01-14 | Rhodes; Valentine J. | Intravascular stent with secure mounting means |
US5609606A (en) * | 1993-02-05 | 1997-03-11 | Joe W. & Dorothy Dorsett Brown Foundation | Ultrasonic angioplasty balloon catheter |
US5628788A (en) * | 1995-11-07 | 1997-05-13 | Corvita Corporation | Self-expanding endoluminal stent-graft |
US5630829A (en) * | 1994-12-09 | 1997-05-20 | Intervascular, Inc. | High hoop strength intraluminal stent |
US5632772A (en) * | 1993-10-21 | 1997-05-27 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
US5707386A (en) * | 1993-02-04 | 1998-01-13 | Angiomed Gmbh & Company Medizintechnik Kg | Stent and method of making a stent |
US5709713A (en) * | 1995-03-31 | 1998-01-20 | Cardiovascular Concepts, Inc. | Radially expansible vascular prosthesis having reversible and other locking structures |
US5709703A (en) * | 1995-11-14 | 1998-01-20 | Schneider (Europe) A.G. | Stent delivery device and method for manufacturing same |
US5716393A (en) * | 1994-05-26 | 1998-02-10 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with an end of greater diameter than its main body |
US5723004A (en) * | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
US5723003A (en) * | 1994-09-13 | 1998-03-03 | Ultrasonic Sensing And Monitoring Systems | Expandable graft assembly and method of use |
US5733303A (en) * | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
US5735892A (en) * | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5735897A (en) * | 1993-10-19 | 1998-04-07 | Scimed Life Systems, Inc. | Intravascular stent pump |
US5738817A (en) * | 1996-02-08 | 1998-04-14 | Rutgers, The State University | Solid freeform fabrication methods |
US5741327A (en) * | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US5741325A (en) * | 1993-10-01 | 1998-04-21 | Emory University | Self-expanding intraluminal composite prosthesis |
US5743874A (en) * | 1994-08-29 | 1998-04-28 | Fischell; Robert E. | Integrated catheter for balloon angioplasty and stent delivery |
US5749880A (en) * | 1995-03-10 | 1998-05-12 | Impra, Inc. | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery |
US5755771A (en) * | 1994-11-03 | 1998-05-26 | Divysio Solutions Ulc | Expandable stent and method of delivery of same |
US5776161A (en) * | 1995-10-16 | 1998-07-07 | Instent, Inc. | Medical stents, apparatus and method for making same |
US5782904A (en) * | 1993-09-30 | 1998-07-21 | Endogad Research Pty Limited | Intraluminal graft |
US5824045A (en) * | 1996-10-21 | 1998-10-20 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US5855600A (en) * | 1997-08-01 | 1999-01-05 | Inflow Dynamics Inc. | Flexible implantable stent with composite design |
US5861027A (en) * | 1996-04-10 | 1999-01-19 | Variomed Ag | Stent for the transluminal implantation in hollow organs |
US5868781A (en) * | 1996-10-22 | 1999-02-09 | Scimed Life Systems, Inc. | Locking stent |
US5871538A (en) * | 1992-12-21 | 1999-02-16 | Corvita Corporation | Luminal graft endoprotheses and manufacture thereof |
US5876449A (en) * | 1995-04-01 | 1999-03-02 | Variomed Ag | Stent for the transluminal implantation in hollow organs |
US5876450A (en) * | 1997-05-09 | 1999-03-02 | Johlin, Jr.; Frederick C. | Stent for draining the pancreatic and biliary ducts and instrumentation for the placement thereof |
US5895406A (en) * | 1996-01-26 | 1999-04-20 | Cordis Corporation | Axially flexible stent |
US5897589A (en) * | 1996-07-10 | 1999-04-27 | B.Braun Celsa | Endoluminal medical implant |
US6017365A (en) * | 1997-05-20 | 2000-01-25 | Jomed Implantate Gmbh | Coronary stent |
US6019789A (en) * | 1998-04-01 | 2000-02-01 | Quanam Medical Corporation | Expandable unit cell and intraluminal stent |
US6027526A (en) * | 1996-04-10 | 2000-02-22 | Advanced Cardiovascular Systems, Inc. | Stent having varied amounts of structural strength along its length |
US6033433A (en) * | 1997-04-25 | 2000-03-07 | Scimed Life Systems, Inc. | Stent configurations including spirals |
US6033434A (en) * | 1995-06-08 | 2000-03-07 | Ave Galway Limited | Bifurcated endovascular stent and methods for forming and placing |
US6033435A (en) * | 1997-11-03 | 2000-03-07 | Divysio Solutions Ulc | Bifurcated stent and method for the manufacture and delivery of same |
WO2000018328A1 (en) * | 1998-09-30 | 2000-04-06 | Impra, Inc. | Selective adherence of stent-graft coverings, mandrel and method of making stent-graft device |
US6048361A (en) * | 1997-05-17 | 2000-04-11 | Jomed Implantate Gmbh | Balloon catheter and multi-guidewire stent for implanting in the region of branched vessels |
US6136023A (en) * | 1996-04-16 | 2000-10-24 | Medtronic, Inc. | Welded sinusoidal wave stent |
US6168409B1 (en) * | 1998-11-13 | 2001-01-02 | Rosaldo Fare | Apparatus for making two component fibers or continuous filaments using flexible tube inserts |
US6174326B1 (en) * | 1996-09-25 | 2001-01-16 | Terumo Kabushiki Kaisha | Radiopaque, antithrombogenic stent and method for its production |
US6179868B1 (en) * | 1998-03-27 | 2001-01-30 | Janet Burpee | Stent with reduced shortening |
US6190403B1 (en) * | 1998-11-13 | 2001-02-20 | Cordis Corporation | Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity |
US6193747B1 (en) * | 1997-02-17 | 2001-02-27 | Jomed Implantate Gmbh | Stent |
US6193744B1 (en) * | 1998-09-10 | 2001-02-27 | Scimed Life Systems, Inc. | Stent configurations |
US6200334B1 (en) * | 1998-02-03 | 2001-03-13 | G. David Jang | Tubular stent consists of non-parallel expansion struts and contralaterally attached diagonal connectors |
US6200335B1 (en) * | 1997-03-31 | 2001-03-13 | Kabushikikaisha Igaki Iryo Sekkei | Stent for vessel |
US6203569B1 (en) * | 1996-01-04 | 2001-03-20 | Bandula Wijay | Flexible stent |
US6340366B2 (en) * | 1998-12-08 | 2002-01-22 | Bandula Wijay | Stent with nested or overlapping rings |
US20020019660A1 (en) * | 1998-09-05 | 2002-02-14 | Marc Gianotti | Methods and apparatus for a curved stent |
US6348065B1 (en) * | 1995-03-01 | 2002-02-19 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
US6377835B1 (en) * | 2000-08-30 | 2002-04-23 | Siemens Aktiengesellschaft | Method for separating arteries and veins in 3D MR angiographic images using correlation analysis |
US6503272B2 (en) * | 2001-03-21 | 2003-01-07 | Cordis Corporation | Stent-based venous valves |
US6506211B1 (en) * | 2000-11-13 | 2003-01-14 | Scimed Life Systems, Inc. | Stent designs |
US6508834B1 (en) * | 1994-03-17 | 2003-01-21 | Medinol Ltd. | Articulated stent |
US20030055487A1 (en) * | 2001-09-18 | 2003-03-20 | Jomed Nv | Stent |
US6540776B2 (en) * | 2000-12-28 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Sheath for a prosthesis and methods of forming the same |
US6652574B1 (en) * | 2000-09-28 | 2003-11-25 | Vascular Concepts Holdings Limited | Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer |
US20040002753A1 (en) * | 2002-06-28 | 2004-01-01 | Robert Burgermeister | Stent with diagonal flexible connecting links |
US6676701B2 (en) * | 2000-02-01 | 2004-01-13 | Endotex Interventional Systems, Inc. | Micro-porous mesh stent with hybrid structure |
US6679911B2 (en) * | 2001-03-01 | 2004-01-20 | Cordis Corporation | Flexible stent |
US6682554B2 (en) * | 1998-09-05 | 2004-01-27 | Jomed Gmbh | Methods and apparatus for a stent having an expandable web structure |
US20040051201A1 (en) * | 2002-04-11 | 2004-03-18 | Greenhalgh Skott E. | Coated stent and method for coating by treating an electrospun covering with heat or chemicals |
US6723119B2 (en) * | 2000-03-01 | 2004-04-20 | Medinol Ltd. | Longitudinally flexible stent |
US6761733B2 (en) * | 2001-04-11 | 2004-07-13 | Trivascular, Inc. | Delivery system and method for bifurcated endovascular graft |
US6846323B2 (en) * | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US20050075716A1 (en) * | 2000-05-04 | 2005-04-07 | Avantec Vascular Corporation | Flexible stent structure |
US6881222B2 (en) * | 1999-10-13 | 2005-04-19 | Endosystems Llc | Non-foreshortening intraluminal prosthesis |
US20060015173A1 (en) * | 2003-05-06 | 2006-01-19 | Anton Clifford | Endoprosthesis having foot extensions |
US6998060B2 (en) * | 2001-03-01 | 2006-02-14 | Cordis Corporation | Flexible stent and method of manufacture |
US7029493B2 (en) * | 2002-01-25 | 2006-04-18 | Cordis Corporation | Stent with enhanced crossability |
US20070021834A1 (en) * | 2003-05-06 | 2007-01-25 | Eugene Young | Endoprosthesis having foot extensions |
US20070021827A1 (en) * | 2002-05-08 | 2007-01-25 | David Lowe | Endoprosthesis Having Foot Extensions |
US7204848B1 (en) * | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US7329277B2 (en) * | 1997-06-13 | 2008-02-12 | Orbusneich Medical, Inc. | Stent having helical elements |
US20080077231A1 (en) * | 2006-07-06 | 2008-03-27 | Prescient Medical, Inc. | Expandable vascular endoluminal prostheses |
US7520892B1 (en) * | 2001-06-28 | 2009-04-21 | Advanced Cardiovascular Systems, Inc. | Low profile stent with flexible link |
US20100057190A1 (en) * | 2007-01-09 | 2010-03-04 | Stentys S.A.S. | Frangible bridge structure for a stent, and stent including such bridge structures |
US7686843B2 (en) * | 2002-07-31 | 2010-03-30 | Unison Therapeutics, Inc. | Flexible and conformable stent |
Family Cites Families (133)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4475972A (en) | 1981-10-01 | 1984-10-09 | Ontario Research Foundation | Implantable material |
US4580568A (en) | 1984-10-01 | 1986-04-08 | Cook, Incorporated | Percutaneous endovascular stent and method for insertion thereof |
US4907336A (en) | 1987-03-13 | 1990-03-13 | Cook Incorporated | Method of making an endovascular stent and delivery system |
US5041126A (en) | 1987-03-13 | 1991-08-20 | Cook Incorporated | Endovascular stent and delivery system |
US5059211A (en) | 1987-06-25 | 1991-10-22 | Duke University | Absorbable vascular stent |
US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US5171262A (en) | 1989-06-15 | 1992-12-15 | Cordis Corporation | Non-woven endoprosthesis |
US5122154A (en) | 1990-08-15 | 1992-06-16 | Rhodes Valentine J | Endovascular bypass graft |
US5163951A (en) | 1990-12-27 | 1992-11-17 | Corvita Corporation | Mesh composite graft |
US5147370A (en) | 1991-06-12 | 1992-09-15 | Mcnamara Thomas O | Nitinol stent for hollow body conduits |
US5370683A (en) | 1992-03-25 | 1994-12-06 | Cook Incorporated | Vascular stent |
US5443458A (en) | 1992-12-22 | 1995-08-22 | Advanced Cardiovascular Systems, Inc. | Multilayered biodegradable stent and method of manufacture |
US5824048A (en) | 1993-04-26 | 1998-10-20 | Medtronic, Inc. | Method for delivering a therapeutic substance to a body lumen |
US5639278A (en) | 1993-10-21 | 1997-06-17 | Corvita Corporation | Expandable supportive bifurcated endoluminal grafts |
US5855598A (en) | 1993-10-21 | 1999-01-05 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
JP2703510B2 (en) | 1993-12-28 | 1998-01-26 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Expandable stent and method of manufacturing the same |
US5843120A (en) | 1994-03-17 | 1998-12-01 | Medinol Ltd. | Flexible-expandable stent |
CA2188563C (en) | 1994-04-29 | 2005-08-02 | Andrew W. Buirge | Stent with collagen |
US5476508A (en) | 1994-05-26 | 1995-12-19 | Tfx Medical | Stent with mutually interlocking filaments |
DE69530891T2 (en) | 1994-06-27 | 2004-05-13 | Corvita Corp., Miami | Bistable luminal graft endoprostheses |
IL115756A0 (en) | 1994-10-27 | 1996-01-19 | Medinol Ltd | Stent fabrication method |
US5836964A (en) | 1996-10-30 | 1998-11-17 | Medinol Ltd. | Stent fabrication method |
AU3783195A (en) | 1994-11-15 | 1996-05-23 | Advanced Cardiovascular Systems Inc. | Intraluminal stent for attaching a graft |
US5674277A (en) | 1994-12-23 | 1997-10-07 | Willy Rusch Ag | Stent for placement in a body tube |
DE4446036C2 (en) | 1994-12-23 | 1999-06-02 | Ruesch Willy Ag | Placeholder for placement in a body tube |
US6231600B1 (en) | 1995-02-22 | 2001-05-15 | Scimed Life Systems, Inc. | Stents with hybrid coating for medical devices |
US6818014B2 (en) | 1995-03-01 | 2004-11-16 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
US5556414A (en) | 1995-03-08 | 1996-09-17 | Wayne State University | Composite intraluminal graft |
CA2171896C (en) | 1995-03-17 | 2007-05-15 | Scott C. Anderson | Multi-anchor stent |
US5674242A (en) | 1995-06-06 | 1997-10-07 | Quanam Medical Corporation | Endoprosthetic device with therapeutic compound |
US6261318B1 (en) | 1995-07-25 | 2001-07-17 | Medstent Inc. | Expandable stent |
PL184769B1 (en) | 1995-07-25 | 2002-12-31 | Medstent Inc | Expandible stent's mass |
US5824037A (en) | 1995-10-03 | 1998-10-20 | Medtronic, Inc. | Modular intraluminal prostheses construction and methods |
US5810868A (en) | 1995-12-07 | 1998-09-22 | Arterial Vascular Engineering, Inc. | Stent for improved transluminal deployment |
US5843158A (en) | 1996-01-05 | 1998-12-01 | Medtronic, Inc. | Limited expansion endoluminal prostheses and methods for their use |
US5938682A (en) | 1996-01-26 | 1999-08-17 | Cordis Corporation | Axially flexible stent |
US6258116B1 (en) | 1996-01-26 | 2001-07-10 | Cordis Corporation | Bifurcated axially flexible stent |
ES2212079T3 (en) | 1996-02-15 | 2004-07-16 | Biosense, Inc. | POSITION MARKER PROBE. |
US5695516A (en) | 1996-02-21 | 1997-12-09 | Iso Stent, Inc. | Longitudinally elongating balloon expandable stent |
CA2199890C (en) | 1996-03-26 | 2002-02-05 | Leonard Pinchuk | Stents and stent-grafts having enhanced hoop strength and methods of making the same |
US6039756A (en) | 1996-04-26 | 2000-03-21 | Jang; G. David | Intravascular stent |
US5922021A (en) | 1996-04-26 | 1999-07-13 | Jang; G. David | Intravascular stent |
US5954743A (en) | 1996-04-26 | 1999-09-21 | Jang; G. David | Intravascular stent |
EP0808614B1 (en) | 1996-05-23 | 2003-02-26 | Samsung Electronics Co., Ltd. | Flexible self-expandable stent and method for making the same |
US5670161A (en) | 1996-05-28 | 1997-09-23 | Healy; Kevin E. | Biodegradable stent |
US5697971A (en) | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
US5843161A (en) | 1996-06-26 | 1998-12-01 | Cordis Corporation | Endoprosthesis assembly for percutaneous deployment and method of deploying same |
US5769884A (en) | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
US5755781A (en) | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
US5776183A (en) | 1996-08-23 | 1998-07-07 | Kanesaka; Nozomu | Expandable stent |
US5807404A (en) | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US6099561A (en) | 1996-10-21 | 2000-08-08 | Inflow Dynamics, Inc. | Vascular and endoluminal stents with improved coatings |
US6086610A (en) | 1996-10-22 | 2000-07-11 | Nitinol Devices & Components | Composite self expanding stent device having a restraining element |
US6162537A (en) * | 1996-11-12 | 2000-12-19 | Solutia Inc. | Implantable fibers and medical articles |
WO1998020810A1 (en) | 1996-11-12 | 1998-05-22 | Medtronic, Inc. | Flexible, radially expansible luminal prostheses |
US5846247A (en) | 1996-11-15 | 1998-12-08 | Unsworth; John D. | Shape memory tubular deployment system |
IL131063A (en) | 1997-01-24 | 2005-07-25 | Kentucky Oil N V | Bistable spring construction for a stent and other medical apparatus |
US5827321A (en) | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US5928248A (en) | 1997-02-14 | 1999-07-27 | Biosense, Inc. | Guided deployment of stents |
US5810872A (en) | 1997-03-14 | 1998-09-22 | Kanesaka; Nozomu | Flexible stent |
US5853419A (en) | 1997-03-17 | 1998-12-29 | Surface Genesis, Inc. | Stent |
US5817126A (en) | 1997-03-17 | 1998-10-06 | Surface Genesis, Inc. | Compound stent |
US5824054A (en) | 1997-03-18 | 1998-10-20 | Endotex Interventional Systems, Inc. | Coiled sheet graft stent and methods of making and use |
US6273913B1 (en) | 1997-04-18 | 2001-08-14 | Cordis Corporation | Modified stent useful for delivery of drugs along stent strut |
US6451049B2 (en) | 1998-04-29 | 2002-09-17 | Sorin Biomedica Cardio, S.P.A. | Stents for angioplasty |
DE29708689U1 (en) | 1997-05-15 | 1997-07-17 | Jomed Implantate Gmbh | Coronary stent |
US5836966A (en) | 1997-05-22 | 1998-11-17 | Scimed Life Systems, Inc. | Variable expansion force stent |
EP0890346A1 (en) | 1997-06-13 | 1999-01-13 | Gary J. Becker | Expandable intraluminal endoprosthesis |
EP0884029B1 (en) | 1997-06-13 | 2004-12-22 | Gary J. Becker | Expandable intraluminal endoprosthesis |
US5824059A (en) | 1997-08-05 | 1998-10-20 | Wijay; Bandula | Flexible stent |
US5984965A (en) | 1997-08-28 | 1999-11-16 | Urosurge, Inc. | Anti-reflux reinforced stent |
ES2290995T3 (en) | 1997-09-24 | 2008-02-16 | Med Institute, Inc. | RADIALLY EXPANDABLE ENDOPROTESIS. |
US6042606A (en) | 1997-09-29 | 2000-03-28 | Cook Incorporated | Radially expandable non-axially contracting surgical stent |
US5972027A (en) | 1997-09-30 | 1999-10-26 | Scimed Life Systems, Inc | Porous stent drug delivery system |
US6071308A (en) | 1997-10-01 | 2000-06-06 | Boston Scientific Corporation | Flexible metal wire stent |
US6129755A (en) | 1998-01-09 | 2000-10-10 | Nitinol Development Corporation | Intravascular stent having an improved strut configuration |
US6117535A (en) * | 1998-01-14 | 2000-09-12 | Cardiotech International, Inc. | Biocompatible devices |
FR2774279B3 (en) | 1998-02-03 | 2000-04-07 | Braun Celsa Sa | STRUCTURED ENDOPROSTHESIS WITH ZIGZAG SHAFTS AND ARTICULATED TIES |
US6113627A (en) | 1998-02-03 | 2000-09-05 | Jang; G. David | Tubular stent consists of horizontal expansion struts and contralaterally attached diagonal-connectors |
WO1999040876A2 (en) | 1998-02-17 | 1999-08-19 | Jang G David | Tubular stent consists of chevron-shape expansion struts and ipsilaterally attached m-frame connectors |
WO1999044543A1 (en) | 1998-03-04 | 1999-09-10 | Scimed Life Systems, Inc. | Improved stent cell configurations |
US6558415B2 (en) | 1998-03-27 | 2003-05-06 | Intratherapeutics, Inc. | Stent |
US6132460A (en) | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent |
US6241762B1 (en) | 1998-03-30 | 2001-06-05 | Conor Medsystems, Inc. | Expandable medical device with ductile hinges |
DE19829702C1 (en) | 1998-07-03 | 2000-03-16 | Heraeus Gmbh W C | Radially expandable support device V |
CA2340652C (en) | 1998-08-20 | 2013-09-24 | Cook Incorporated | Coated implantable medical device comprising paclitaxel |
DE19839646A1 (en) | 1998-08-31 | 2000-03-09 | Jomed Implantate Gmbh | Stent |
US6755856B2 (en) | 1998-09-05 | 2004-06-29 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
US7887578B2 (en) | 1998-09-05 | 2011-02-15 | Abbott Laboratories Vascular Enterprises Limited | Stent having an expandable web structure |
DE19840645A1 (en) | 1998-09-05 | 2000-03-09 | Jomed Implantate Gmbh | Stent |
US6540780B1 (en) | 1998-11-23 | 2003-04-01 | Medtronic, Inc. | Porous synthetic vascular grafts with oriented ingrowth channels |
GB2344053A (en) | 1998-11-30 | 2000-05-31 | Imperial College | Stents for blood vessels |
SG75982A1 (en) | 1998-12-03 | 2000-10-24 | Medinol Ltd | Controlled detachment stents |
US6325825B1 (en) | 1999-04-08 | 2001-12-04 | Cordis Corporation | Stent with variable wall thickness |
US6409754B1 (en) | 1999-07-02 | 2002-06-25 | Scimed Life Systems, Inc. | Flexible segmented stent |
WO2001028454A2 (en) | 1999-10-05 | 2001-04-26 | Amjad Ahmad | Intra vascular stent |
US6331189B1 (en) | 1999-10-18 | 2001-12-18 | Medtronic, Inc. | Flexible medical stent |
DE19951475A1 (en) | 1999-10-26 | 2001-05-10 | Biotronik Mess & Therapieg | Stent |
US7141062B1 (en) | 2000-03-01 | 2006-11-28 | Medinol, Ltd. | Longitudinally flexible stent |
US6436132B1 (en) | 2000-03-30 | 2002-08-20 | Advanced Cardiovascular Systems, Inc. | Composite intraluminal prostheses |
US20030114918A1 (en) | 2000-04-28 | 2003-06-19 | Garrison Michi E. | Stent graft assembly and method |
US6616689B1 (en) | 2000-05-03 | 2003-09-09 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US6554848B2 (en) | 2000-06-02 | 2003-04-29 | Advanced Cardiovascular Systems, Inc. | Marker device for rotationally orienting a stent delivery system prior to deploying a curved self-expanding stent |
US6572646B1 (en) | 2000-06-02 | 2003-06-03 | Advanced Cardiovascular Systems, Inc. | Curved nitinol stent for extremely tortuous anatomy |
US6730252B1 (en) * | 2000-09-20 | 2004-05-04 | Swee Hin Teoh | Methods for fabricating a filament for use in tissue engineering |
US6699278B2 (en) | 2000-09-22 | 2004-03-02 | Cordis Corporation | Stent with optimal strength and radiopacity characteristics |
US6485508B1 (en) | 2000-10-13 | 2002-11-26 | Mcguinness Colm P. | Low profile stent |
US6758859B1 (en) | 2000-10-30 | 2004-07-06 | Kenny L. Dang | Increased drug-loading and reduced stress drug delivery device |
US6929660B1 (en) | 2000-12-22 | 2005-08-16 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US6955686B2 (en) | 2001-03-01 | 2005-10-18 | Cordis Corporation | Flexible stent |
US6790227B2 (en) | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US6629994B2 (en) | 2001-06-11 | 2003-10-07 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US6749629B1 (en) | 2001-06-27 | 2004-06-15 | Advanced Cardiovascular Systems, Inc. | Stent pattern with figure-eights |
US6607554B2 (en) | 2001-06-29 | 2003-08-19 | Advanced Cardiovascular Systems, Inc. | Universal stent link design |
SG108867A1 (en) | 2001-09-06 | 2005-02-28 | Medinol Ltd | Self articulating stent |
USD481139S1 (en) | 2001-09-17 | 2003-10-21 | Jomed Nv | Stent wall structure |
US6776794B1 (en) | 2001-11-28 | 2004-08-17 | Advanced Cardiovascular Systems, Inc. | Stent pattern with mirror image |
US7537607B2 (en) | 2001-12-21 | 2009-05-26 | Boston Scientific Scimed, Inc. | Stent geometry for improved flexibility |
US6786922B2 (en) | 2002-10-08 | 2004-09-07 | Cook Incorporated | Stent with ring architecture and axially displaced connector segments |
US20040126405A1 (en) | 2002-12-30 | 2004-07-01 | Scimed Life Systems, Inc. | Engineered scaffolds for promoting growth of cells |
US7625398B2 (en) | 2003-05-06 | 2009-12-01 | Abbott Laboratories | Endoprosthesis having foot extensions |
US6916336B2 (en) | 2003-06-09 | 2005-07-12 | Avantec Vascular Corporation | Vascular prosthesis |
US20050222671A1 (en) | 2004-03-31 | 2005-10-06 | Schaeffer Darin G | Partially biodegradable stent |
US7867272B2 (en) | 2004-10-26 | 2011-01-11 | Cordis Corporation | Stent having twist cancellation geometry |
CA2610108C (en) | 2005-04-04 | 2014-03-25 | Burpee Materials Technology, Llc | Flexible stent |
EP2051673A2 (en) | 2006-06-23 | 2009-04-29 | Boston Scientific Limited | Bifurcated stent with twisted hinges |
US8778009B2 (en) | 2006-10-06 | 2014-07-15 | Abbott Cardiovascular Systems Inc. | Intravascular stent |
US8016874B2 (en) | 2007-05-23 | 2011-09-13 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with elevated scaffolding properties |
US8128679B2 (en) | 2007-05-23 | 2012-03-06 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
US20090163998A1 (en) | 2007-12-20 | 2009-06-25 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having rings linked by foot extensions |
US8337544B2 (en) | 2007-12-20 | 2012-12-25 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having flexible connectors |
US7850726B2 (en) | 2007-12-20 | 2010-12-14 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having struts linked by foot extensions |
US8920488B2 (en) | 2007-12-20 | 2014-12-30 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having a stable architecture |
-
2005
- 2005-12-19 US US11/313,110 patent/US7815763B2/en not_active Expired - Fee Related
-
2010
- 2010-09-30 US US12/895,032 patent/US20110022159A1/en not_active Abandoned
Patent Citations (110)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4759757A (en) * | 1984-04-18 | 1988-07-26 | Corvita Corporation | Cardiovascular graft and method of forming same |
US5102417A (en) * | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4738740A (en) * | 1985-11-21 | 1988-04-19 | Corvita Corporation | Method of forming implantable vascular grafts |
US4743252A (en) * | 1986-01-13 | 1988-05-10 | Corvita Corporation | Composite grafts |
US5314444A (en) * | 1987-03-13 | 1994-05-24 | Cook Incorporated | Endovascular stent and delivery system |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US5019090A (en) * | 1988-09-01 | 1991-05-28 | Corvita Corporation | Radially expandable endoprosthesis and the like |
US5015253A (en) * | 1989-06-15 | 1991-05-14 | Cordis Corporation | Non-woven endoprosthesis |
US5292331A (en) * | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
US5104404A (en) * | 1989-10-02 | 1992-04-14 | Medtronic, Inc. | Articulated stent |
US5496277A (en) * | 1990-04-12 | 1996-03-05 | Schneider (Usa) Inc. | Radially expandable body implantable device |
US5378239A (en) * | 1990-04-12 | 1995-01-03 | Schneider (Usa) Inc. | Radially expandable fixation member constructed of recovery metal |
US5116360A (en) * | 1990-12-27 | 1992-05-26 | Corvita Corporation | Mesh composite graft |
US5527354A (en) * | 1991-06-28 | 1996-06-18 | Cook Incorporated | Stent formed of half-round wire |
US5514154A (en) * | 1991-10-28 | 1996-05-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents |
US5728158A (en) * | 1991-10-28 | 1998-03-17 | Advanced Cardiovascular Systems, Inc. | Expandable stents |
US5735893A (en) * | 1991-10-28 | 1998-04-07 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5603721A (en) * | 1991-10-28 | 1997-02-18 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
US5282823A (en) * | 1992-03-19 | 1994-02-01 | Medtronic, Inc. | Intravascular radially expandable stent |
US5591224A (en) * | 1992-03-19 | 1997-01-07 | Medtronic, Inc. | Bioelastomeric stent |
EP0565251A1 (en) * | 1992-03-25 | 1993-10-13 | Cook Incorporated | Vascular stent |
US5449382A (en) * | 1992-11-04 | 1995-09-12 | Dayton; Michael P. | Minimally invasive bioactivated endoprosthesis for vessel repair |
US5871538A (en) * | 1992-12-21 | 1999-02-16 | Corvita Corporation | Luminal graft endoprotheses and manufacture thereof |
US5860999A (en) * | 1993-02-04 | 1999-01-19 | Angiomed Gmbh & Co.Medizintechnik Kg | Stent and method of using same |
US5707386A (en) * | 1993-02-04 | 1998-01-13 | Angiomed Gmbh & Company Medizintechnik Kg | Stent and method of making a stent |
US5609606A (en) * | 1993-02-05 | 1997-03-11 | Joe W. & Dorothy Dorsett Brown Foundation | Ultrasonic angioplasty balloon catheter |
US5735892A (en) * | 1993-08-18 | 1998-04-07 | W. L. Gore & Associates, Inc. | Intraluminal stent graft |
US5380299A (en) * | 1993-08-30 | 1995-01-10 | Med Institute, Inc. | Thrombolytic treated intravascular medical device |
US5782904A (en) * | 1993-09-30 | 1998-07-21 | Endogad Research Pty Limited | Intraluminal graft |
US5741325A (en) * | 1993-10-01 | 1998-04-21 | Emory University | Self-expanding intraluminal composite prosthesis |
US5735897A (en) * | 1993-10-19 | 1998-04-07 | Scimed Life Systems, Inc. | Intravascular stent pump |
US5723004A (en) * | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
US5632772A (en) * | 1993-10-21 | 1997-05-27 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
US6875228B2 (en) * | 1994-03-17 | 2005-04-05 | Medinol, Ltd. | Articulated stent |
US6508834B1 (en) * | 1994-03-17 | 2003-01-21 | Medinol Ltd. | Articulated stent |
US5733303A (en) * | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
US5716393A (en) * | 1994-05-26 | 1998-02-10 | Angiomed Gmbh & Co. Medizintechnik Kg | Stent with an end of greater diameter than its main body |
US5743874A (en) * | 1994-08-29 | 1998-04-28 | Fischell; Robert E. | Integrated catheter for balloon angioplasty and stent delivery |
US5723003A (en) * | 1994-09-13 | 1998-03-03 | Ultrasonic Sensing And Monitoring Systems | Expandable graft assembly and method of use |
US5755771A (en) * | 1994-11-03 | 1998-05-26 | Divysio Solutions Ulc | Expandable stent and method of delivery of same |
US5630829A (en) * | 1994-12-09 | 1997-05-20 | Intervascular, Inc. | High hoop strength intraluminal stent |
US5707388A (en) * | 1994-12-09 | 1998-01-13 | Intervascular, Inc. | High hoop strength intraluminal stent |
US6348065B1 (en) * | 1995-03-01 | 2002-02-19 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
US7204848B1 (en) * | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US5749880A (en) * | 1995-03-10 | 1998-05-12 | Impra, Inc. | Endoluminal encapsulated stent and methods of manufacture and endoluminal delivery |
US5591197A (en) * | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
US5709713A (en) * | 1995-03-31 | 1998-01-20 | Cardiovascular Concepts, Inc. | Radially expansible vascular prosthesis having reversible and other locking structures |
US5876449A (en) * | 1995-04-01 | 1999-03-02 | Variomed Ag | Stent for the transluminal implantation in hollow organs |
US5593442A (en) * | 1995-06-05 | 1997-01-14 | Localmed, Inc. | Radially expansible and articulated vessel scaffold |
US6033434A (en) * | 1995-06-08 | 2000-03-07 | Ave Galway Limited | Bifurcated endovascular stent and methods for forming and placing |
US5776161A (en) * | 1995-10-16 | 1998-07-07 | Instent, Inc. | Medical stents, apparatus and method for making same |
US5628788A (en) * | 1995-11-07 | 1997-05-13 | Corvita Corporation | Self-expanding endoluminal stent-graft |
US5709703A (en) * | 1995-11-14 | 1998-01-20 | Schneider (Europe) A.G. | Stent delivery device and method for manufacturing same |
US5593417A (en) * | 1995-11-27 | 1997-01-14 | Rhodes; Valentine J. | Intravascular stent with secure mounting means |
US6203569B1 (en) * | 1996-01-04 | 2001-03-20 | Bandula Wijay | Flexible stent |
US5895406A (en) * | 1996-01-26 | 1999-04-20 | Cordis Corporation | Axially flexible stent |
US5738817A (en) * | 1996-02-08 | 1998-04-14 | Rutgers, The State University | Solid freeform fabrication methods |
US5861027A (en) * | 1996-04-10 | 1999-01-19 | Variomed Ag | Stent for the transluminal implantation in hollow organs |
US6027526A (en) * | 1996-04-10 | 2000-02-22 | Advanced Cardiovascular Systems, Inc. | Stent having varied amounts of structural strength along its length |
US6136023A (en) * | 1996-04-16 | 2000-10-24 | Medtronic, Inc. | Welded sinusoidal wave stent |
US5897589A (en) * | 1996-07-10 | 1999-04-27 | B.Braun Celsa | Endoluminal medical implant |
US6174326B1 (en) * | 1996-09-25 | 2001-01-16 | Terumo Kabushiki Kaisha | Radiopaque, antithrombogenic stent and method for its production |
US5824045A (en) * | 1996-10-21 | 1998-10-20 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US5868781A (en) * | 1996-10-22 | 1999-02-09 | Scimed Life Systems, Inc. | Locking stent |
US6193747B1 (en) * | 1997-02-17 | 2001-02-27 | Jomed Implantate Gmbh | Stent |
US6200335B1 (en) * | 1997-03-31 | 2001-03-13 | Kabushikikaisha Igaki Iryo Sekkei | Stent for vessel |
US6033433A (en) * | 1997-04-25 | 2000-03-07 | Scimed Life Systems, Inc. | Stent configurations including spirals |
US5741327A (en) * | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
US5876450A (en) * | 1997-05-09 | 1999-03-02 | Johlin, Jr.; Frederick C. | Stent for draining the pancreatic and biliary ducts and instrumentation for the placement thereof |
US6048361A (en) * | 1997-05-17 | 2000-04-11 | Jomed Implantate Gmbh | Balloon catheter and multi-guidewire stent for implanting in the region of branched vessels |
US6017365A (en) * | 1997-05-20 | 2000-01-25 | Jomed Implantate Gmbh | Coronary stent |
US7329277B2 (en) * | 1997-06-13 | 2008-02-12 | Orbusneich Medical, Inc. | Stent having helical elements |
US5855600A (en) * | 1997-08-01 | 1999-01-05 | Inflow Dynamics Inc. | Flexible implantable stent with composite design |
US6033435A (en) * | 1997-11-03 | 2000-03-07 | Divysio Solutions Ulc | Bifurcated stent and method for the manufacture and delivery of same |
US6200334B1 (en) * | 1998-02-03 | 2001-03-13 | G. David Jang | Tubular stent consists of non-parallel expansion struts and contralaterally attached diagonal connectors |
US6179868B1 (en) * | 1998-03-27 | 2001-01-30 | Janet Burpee | Stent with reduced shortening |
US6019789A (en) * | 1998-04-01 | 2000-02-01 | Quanam Medical Corporation | Expandable unit cell and intraluminal stent |
US20020019660A1 (en) * | 1998-09-05 | 2002-02-14 | Marc Gianotti | Methods and apparatus for a curved stent |
US20050004659A1 (en) * | 1998-09-05 | 2005-01-06 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stent having an expandable web structure |
US20110004289A1 (en) * | 1998-09-05 | 2011-01-06 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for a stent having an expandable web structure |
US6682554B2 (en) * | 1998-09-05 | 2004-01-27 | Jomed Gmbh | Methods and apparatus for a stent having an expandable web structure |
US6193744B1 (en) * | 1998-09-10 | 2001-02-27 | Scimed Life Systems, Inc. | Stent configurations |
WO2000018328A1 (en) * | 1998-09-30 | 2000-04-06 | Impra, Inc. | Selective adherence of stent-graft coverings, mandrel and method of making stent-graft device |
US6190403B1 (en) * | 1998-11-13 | 2001-02-20 | Cordis Corporation | Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity |
US6168409B1 (en) * | 1998-11-13 | 2001-01-02 | Rosaldo Fare | Apparatus for making two component fibers or continuous filaments using flexible tube inserts |
US6340366B2 (en) * | 1998-12-08 | 2002-01-22 | Bandula Wijay | Stent with nested or overlapping rings |
US6881222B2 (en) * | 1999-10-13 | 2005-04-19 | Endosystems Llc | Non-foreshortening intraluminal prosthesis |
US6676701B2 (en) * | 2000-02-01 | 2004-01-13 | Endotex Interventional Systems, Inc. | Micro-porous mesh stent with hybrid structure |
US6723119B2 (en) * | 2000-03-01 | 2004-04-20 | Medinol Ltd. | Longitudinally flexible stent |
US20050075716A1 (en) * | 2000-05-04 | 2005-04-07 | Avantec Vascular Corporation | Flexible stent structure |
US6377835B1 (en) * | 2000-08-30 | 2002-04-23 | Siemens Aktiengesellschaft | Method for separating arteries and veins in 3D MR angiographic images using correlation analysis |
US6652574B1 (en) * | 2000-09-28 | 2003-11-25 | Vascular Concepts Holdings Limited | Product and process for manufacturing a wire stent coated with a biocompatible fluoropolymer |
US6506211B1 (en) * | 2000-11-13 | 2003-01-14 | Scimed Life Systems, Inc. | Stent designs |
US6540776B2 (en) * | 2000-12-28 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Sheath for a prosthesis and methods of forming the same |
US6679911B2 (en) * | 2001-03-01 | 2004-01-20 | Cordis Corporation | Flexible stent |
US6998060B2 (en) * | 2001-03-01 | 2006-02-14 | Cordis Corporation | Flexible stent and method of manufacture |
US6503272B2 (en) * | 2001-03-21 | 2003-01-07 | Cordis Corporation | Stent-based venous valves |
US6761733B2 (en) * | 2001-04-11 | 2004-07-13 | Trivascular, Inc. | Delivery system and method for bifurcated endovascular graft |
US7520892B1 (en) * | 2001-06-28 | 2009-04-21 | Advanced Cardiovascular Systems, Inc. | Low profile stent with flexible link |
US20030055487A1 (en) * | 2001-09-18 | 2003-03-20 | Jomed Nv | Stent |
US7029493B2 (en) * | 2002-01-25 | 2006-04-18 | Cordis Corporation | Stent with enhanced crossability |
US20040051201A1 (en) * | 2002-04-11 | 2004-03-18 | Greenhalgh Skott E. | Coated stent and method for coating by treating an electrospun covering with heat or chemicals |
US20070021827A1 (en) * | 2002-05-08 | 2007-01-25 | David Lowe | Endoprosthesis Having Foot Extensions |
US20040002753A1 (en) * | 2002-06-28 | 2004-01-01 | Robert Burgermeister | Stent with diagonal flexible connecting links |
US7686843B2 (en) * | 2002-07-31 | 2010-03-30 | Unison Therapeutics, Inc. | Flexible and conformable stent |
US20070021834A1 (en) * | 2003-05-06 | 2007-01-25 | Eugene Young | Endoprosthesis having foot extensions |
US20060015173A1 (en) * | 2003-05-06 | 2006-01-19 | Anton Clifford | Endoprosthesis having foot extensions |
US6846323B2 (en) * | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US20080077231A1 (en) * | 2006-07-06 | 2008-03-27 | Prescient Medical, Inc. | Expandable vascular endoluminal prostheses |
US20100057190A1 (en) * | 2007-01-09 | 2010-03-04 | Stentys S.A.S. | Frangible bridge structure for a stent, and stent including such bridge structures |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8814926B2 (en) | 1998-09-05 | 2014-08-26 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
US10420637B2 (en) | 1998-09-05 | 2019-09-24 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
US20110004289A1 (en) * | 1998-09-05 | 2011-01-06 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for a stent having an expandable web structure |
US9517146B2 (en) | 1998-09-05 | 2016-12-13 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
US8303645B2 (en) | 1998-09-05 | 2012-11-06 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for a stent having an expandable web structure |
US8343208B2 (en) | 1998-09-05 | 2013-01-01 | Abbott Laboratories Vascular Enterprises Limited | Stent having an expandable web structure |
US8016874B2 (en) | 2007-05-23 | 2011-09-13 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with elevated scaffolding properties |
US20080294239A1 (en) * | 2007-05-23 | 2008-11-27 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with elevated scaffolding properties |
US9320627B2 (en) | 2007-05-23 | 2016-04-26 | Abbott Laboratories Vascular Enterprises Limited | Flexible stent with torque-absorbing connectors |
US8795577B2 (en) | 2007-11-30 | 2014-08-05 | Cook Medical Technologies Llc | Needle-to-needle electrospinning |
US8246674B2 (en) | 2007-12-20 | 2012-08-21 | Abbott Laboratories Vascular Enterprises Limited | Endoprosthesis having struts linked by foot extensions |
US9856588B2 (en) | 2009-01-16 | 2018-01-02 | Zeus Industrial Products, Inc. | Electrospinning of PTFE |
US20100328087A1 (en) * | 2009-06-28 | 2010-12-30 | Oki Data Corporation | Communication apparatus, connection control method for communication apparatus and method of determining state of communication plug relative to communication connector in communication apparatus |
US20160331512A1 (en) * | 2009-08-07 | 2016-11-17 | Zeus Industrial Products, Inc. | Prosthetic device including electrostatically spun fibrous layer & method for making the same |
US8637109B2 (en) | 2009-12-03 | 2014-01-28 | Cook Medical Technologies Llc | Manufacturing methods for covering endoluminal prostheses |
US20110135806A1 (en) * | 2009-12-03 | 2011-06-09 | David Grewe | Manufacturing methods for covering endoluminal prostheses |
US9175427B2 (en) | 2011-11-14 | 2015-11-03 | Cook Medical Technologies Llc | Electrospun patterned stent graft covering |
US10010395B2 (en) | 2012-04-05 | 2018-07-03 | Zeus Industrial Products, Inc. | Composite prosthetic devices |
US10154918B2 (en) | 2012-12-28 | 2018-12-18 | Cook Medical Technologies Llc | Endoluminal prosthesis with fiber matrix |
US20180139364A1 (en) * | 2013-02-15 | 2018-05-17 | Red.Com, Llc | Dense field imaging |
Also Published As
Publication number | Publication date |
---|---|
US7815763B2 (en) | 2010-10-19 |
US20060175727A1 (en) | 2006-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7815763B2 (en) | Porous membranes for medical implants and methods of manufacture | |
US20130190856A1 (en) | Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation | |
JP4651280B2 (en) | EPTFE coating for endovascular prosthesis | |
US5024671A (en) | Microporous vascular graft | |
US6733524B2 (en) | Polymer coated stent | |
US6156064A (en) | Stent-graft-membrane and method of making the same | |
EP0855170B1 (en) | Stent graft with braided polymeric sleeve as well as its manufacturing method | |
US6821549B2 (en) | Process for coating a surface of a stent | |
US20090171436A1 (en) | Grafts and stent grafts having a radiopaque beading | |
CA2432164A1 (en) | Improved vascular prosthesis and method for production thereof | |
JP2000508216A (en) | Radially expandable tubular PTFE graft with stent | |
AU2005318382B2 (en) | Porous membranes for medical implants and methods of manufacture | |
EP2150286B1 (en) | Methods of making an endovascular prosthesis using a deformable matrix | |
EP1493402A2 (en) | Stent graft with braided polymeric sleeve | |
MX2007000912A (en) | Metallic drug-releasing medical devices and method of making same | |
AU2002322505A1 (en) | ePTFE covering for endovascular prostheses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |